BARCLAYS PLC - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 40 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q1 2019. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BARCLAYS PLC ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q3 2019$0–1
-99.6%
0.00%–
Q2 2019$0
-100.0%
240
-95.9%
0.00%–
Q1 2019$11,000
-76.6%
5,825
-16.0%
0.00%–
Q3 2018$47,000
+42.4%
6,937
+395.9%
0.00%–
Q2 2018$33,000–1,399–0.00%–
 Download
Other shareholders

There were no reported owners of INNOVATE BIOPHARMACEUTICLS I in Q1 2019.

NameSharesValueWeighting ↓
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders